Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir (Q41907710)
Jump to navigation
Jump to search
scientific article published on 11 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir |
scientific article published on 11 November 2013 |
Statements
1 reference
Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir (English)
1 reference
Kristi L Berger
1 reference
Martin Marquis
1 reference
George Kukolj
1 reference
Ibtissem Triki
1 reference
Mireille Cartier
1 reference
Marie-Josée Massariol
1 reference
Wulf O Böcher
1 reference
Yakov Datsenko
1 reference
Gerhard Steinmann
1 reference
Joseph Scherer
1 reference
Jerry O Stern
1 reference
11 November 2013
1 reference
1 reference
Identifiers
1 reference